Bristol-Myers Squibb (BMY)

Index:

S&P 100

$ 47.57
   
  • Change Today:
    $-2.49
  • 52 Week High: $63.11
  • 52 Week Low: $39.66
  • Currency: US Dollars
  • Shares Issued: 2,006.00m
  • Volume: 1,994
  • Market Cap: $95,425m
  • RiskGrade: 106
  • Beta: 0.19

BMY Overview

Bristol-Myers Squibb is a global producer and distributor of pharmaceuticals and other healthcare-related products. The merger of Bristol-Myers with Squibb in 1989 created what was then the world’s second-largest pharmaceutical enterprise. The company’s key business areas cover pharmaceuticals, infant formulas and nutritional products, ostomy & advanced wound care, cardiovascular imaging and over-the-counter products.

1 Day Chart (06-05-2025)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 5.1%
Div Cover -1.8
Op Mrgn -17.3%
ROCE n/a
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue 2.0
Pr/Book 5.8
Latest F'cast
Revenue 7.3%
PBT n/a
EPS n/a
DPS 4.8%

BMY Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 42,518.00 (6,871.00) (399.00)¢ n/a n/a n/a 184.00¢ 3.0%
31-Dec-21 46,385.00 8,098.00 315.00¢ 19.8 n/a n/a 201.00¢ 3.2%
31-Dec-22 46,159.00 7,713.00 297.00¢ 24.2 n/a -6% 219.00¢ 3.0%
31-Dec-23 45,006.00 8,440.00 388.00¢ 13.2 0.4 +31% 231.00¢ 4.5%
31-Dec-24 48,300.00 (8,379.00) (441.00)¢ n/a n/a n/a 242.00¢ 4.3%

BMY Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 46,258.27 17,002.95 688.14¢ 6.9 n/a n/a 248.60¢ 0.0%
31-Dec-26 42,990.40 15,532.27 613.23¢ 7.8 n/a -11% 256.66¢ 0.0%
31-Dec-27 42,593.59 15,501.35 603.79¢ 7.9 n/a -2% 265.09¢ 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

BMY ShareCast News

Bristol Myers Squibb delivers solid Q4 performan... 06-Feb-2025 ShareCast
Bristol Myers Squibb to cut 2,200 jobs as part o... 25-Apr-2024 ShareCast
Bristol Myers Squibb to buy Karuna Therapeutics ... 22-Dec-2023 ShareCast

BMY Top Newspaper Links

Bristol-Myers, partner AstraZeneca get EU approv... 06-Oct-2009 Chicago Tribune
AstraZeneca's heart attack drug offers £5.5bn bo... 31-Aug-2009 Sunday Telegraph
Astra Zeneca gets US approval for diabetes drug ... 02-Aug-2009 Sunday Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

BMY Market Data

Currency US Dollars
Share Price $ 47.57
Change Today $ -2.49
% Change -4.97 %
52 Week High $63.11
52 Week Low $39.66
Volume 1,994
Shares Issued 2,006.00m
Market Cap $95,425m
Beta 0.19
RiskGrade 106

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 18
Sell 2
Strong Sell 0
Total 26
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 06-May-2025

Time Volume / Share Price
15:59 100 @ $47.55
15:59 100 @ $47.56
15:59 100 @ $47.55
15:59 100 @ $47.55
15:59 100 @ $47.56

Top of Page